Free Trial

Owens & Minor (OMI) Stock Forecast & Price Target

$13.74
+0.14 (+1.03%)
(As of 07/12/2024 ET)

Owens & Minor - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$21.88
59.21% Upside
High Forecast$28.00
Average Forecast$21.88
Low Forecast$16.00
TypeCurrent Forecast
7/15/23 to 7/14/24
1 Month Ago
6/15/23 to 6/14/24
3 Months Ago
4/16/23 to 4/15/24
1 Year Ago
7/15/22 to 7/15/23
Consensus Rating
Reduce
Hold
Hold
Reduce
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$21.88$23.29$23.29$18.83
Forecasted Upside59.21% Upside11.81% Upside8.99% Upside21.24% Upside
Get Owens & Minor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

OMI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OMI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Owens & Minor Stock vs. The Competition

TypeOwens & MinorMedical CompaniesS&P 500
Consensus Rating Score
1.89
2.71
2.51
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside59.21% Upside994.16% Upside9.19% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/25/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$18.00 ➝ $16.00+6.81%
6/25/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$24.00 ➝ $20.00+23.69%
4/30/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$24.00 ➝ $28.00+10.41%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$24.00+0.50%
2/21/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00+9.52%
1/29/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$28.00 ➝ $26.00+31.38%
11/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$21.00 ➝ $19.00+3.88%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$18.00 ➝ $19.00-1.30%
10/12/2022Bank Of America (Bofa)
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Underperform$43.00 ➝ $17.00+12.66%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 06:09 PM ET.

OMI Forecast - Frequently Asked Questions

What is Owens & Minor's forecast for 2024?

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Owens & Minor is $21.88, with a high forecast of $28.00 and a low forecast of $16.00.

Should I buy or sell Owens & Minor stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" OMI shares.

Does Owens & Minor's stock price have much upside?

According to analysts, Owens & Minor's stock has a predicted upside of 10.26% based on their 12-month stock forecasts.

What analysts cover Owens & Minor?

Owens & Minor has been rated by research analysts at Bank of America, Citigroup, and Robert W. Baird in the past 90 days.

Do Wall Street analysts like Owens & Minor more than its competitors?

Analysts like Owens & Minor less than other "medical" companies. The consensus rating for Owens & Minor is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OMI compares to other companies.


This page (NYSE:OMI) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners